TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | 5 | -13 | 56 | 58 | 28 | 22 |
| P | %wins | 50 | 100 | 0 | 100 | 100 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/13 16:16 | 3/14/13 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Patrick Gregory S | MD | O | VP,CFO | P.d | 35 | 6.95 | 1 | 5 | 128 | 9 | D | -42 | -11 | -10 | -7 | -11 | -10 | -9 | 0 | -4 | 14 | 15 | 66 | ||
5/7/12 11:56 | 5/4/12 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Patrick Gregory S | MD | O | VP,CFO | P | 15 | 5.00 | 1 | 3 | New | 3 | D | 11 | 6 | 9 | -22 | 98 | 101 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |